EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi

Rebecca M Legere, Jeannine A Ott, Cristina Poveda, Daryll Vanover, Karin E R Borba, Jae Yeon Joo, Cameron L Martin, Bibiana P da Silveira, Jocelyne M Bray, Kerstin Landrock, Gus A Wright, J Chistensen Blazier und 12 weitere

Molecular Therapy · 2025-09 · 33 (9) · 4175-4192

DOI: 10.1016/j.ymthe.2025.06.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025-09. Verfasst von Rebecca M Legere und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX 77843, …. Hauptthemen laut MEDLINE: Rhodococcus equi, Antibodies, Monoclonal, RNA, Messenger, Immunization, Passive. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Food and Agriculture, Grayson Jockey Club Research Foundation Inc, Link Equine Research Endowment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhalation of Rhodococcus equi causes severe pneumonia in humans and animals worldwide, most commonly affecting horse foals. The standard for preventing R. equi pneumonia in foals is transfusion of hyperimmune plasma, which is expensive and carries the risk of adverse effects. Our goal was to passively immunize foals against R. equi by nebulizing mRNA encoding an equine monoclonal antibody (mAb) against the virulence-associated protein A (VapA) directly into the lungs. VapA-specific memory B cells from an immunized horse were used to identify and select the sequence for an equine immunoglobulin (Ig)G1 mAb. In vitro-transcribed mRNA encoding this sequence expressed full-length, VapA-specific mAbs in vitro and safely and effectively produced intrapulmonary mAb in foals for at least 5 days following nebulization. These findings establish a platform to generate mRNA-encoded mAbs for immunotherapeutic and immunoprophylactic applications in horses and demonstrate the feasibility of delivering nebulized mRNA-mAb for intrapulmonary mAb expression in neonates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhodococcus equiAntibodies, MonoclonalRNA, MessengerImmunization, PassiveActinomycetales InfectionsHorse DiseasesAnimalsHorsesBacterial ProteinsNebulizers and Vaporizers

Stichwörter der Autor:innen

Rhodococcus equiaerosolfoalimmunitymRNAmonoclonal antibodynebulizationpoly-beta-amino-thio-estertransfection

Substanzen

Antibodies, MonoclonalRNA, MessengerBacterial ProteinsVapA protein, Rhodococcus equi

Autor:innen und Institutionen

  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
  • Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
  • National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX 77030…
  • Wallace H. Coulter Department of Biomedical Engineering, Emory University & Georgia Institute of Technology, Atlanta, GA 30322, USA.
  • Department of Poultry Science, College of Agriculture & Life Sciences, Texas A&M University, College Station, TX 77843, USA.
  • Texas A&M Institute for Genome Sciences and Society, Texas A&M University, College Station, TX 77843, USA.

Förderung

  • National Institute of Food and Agriculture
  • Grayson Jockey Club Research Foundation Inc
  • Link Equine Research Endowment
  • Texas A and M University
  • Baylor College of Medicine
  • Eterna Therapeutics
  • U.S. Department of Agriculture
  • College of Veterinary Medicine and Biomedical Sciences, Texas A and M University

Zitieren

APA

Legere, R. M., Ott, J. A., Poveda, C., Vanover, D., Borba, K. E. R., Yeon Joo, J., Martin, C. L., da Silveira, B. P., Bray, J. M., Landrock, K., Wright, G. A., Blazier, J. C., Hillhouse, A. E., Benham-Duret, A. L., Mistretta, B., Klein, R. L., Thompson, S. M., Woolums, A. R., Criscitiello, M. F., …, & Cohen, N. D. (2025). Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi. Molecular Therapy, 33(9), 4175-4192. https://doi.org/10.1016/j.ymthe.2025.06.025

Vancouver

Legere RM, Ott JA, Poveda C, Vanover D, Borba KER, Yeon Joo J, et al. Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi. Molecular Therapy. 2025;33(9):4175-4192. doi:10.1016/j.ymthe.2025.06.025

BibTeX
@article{Legere2025,
  author = {Legere, Rebecca M and Ott, Jeannine A and Poveda, Cristina and Vanover, Daryll and Borba, Karin E R and Yeon Joo, Jae and Martin, Cameron L and da Silveira, Bibiana P and Bray, Jocelyne M and Landrock, Kerstin and Wright, Gus A and Blazier, J Chistensen and Hillhouse, Andrew E and Benham-Duret, Ashley L and Mistretta, Brandon and Klein, Rafaela L and Thompson, Sarah M and Woolums, Amelia R and Criscitiello, Michael F and Berghman, Luc R and Bordin, Angela I and Santangelo, Philip J and Pollet, Jeroen and Cohen, Noah D},
  title = {Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi},
  journal = {Molecular Therapy},
  year = {2025},
  volume = {33},
  number = {9},
  pages = {4175--4192},
  doi = {10.1016/j.ymthe.2025.06.025}
}
Kostenlos starten →